63603-10-1

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-amino-4-chloro-5-methoxybenzenecarboxylate is used as an intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 3-amino-4-chloro-5-methoxybenzenecarboxylate serves as an intermediate for the production of agrochemicals. Its properties allow for the creation of compounds that can be used in pest control and crop protection.
Used in Dye and Pigment Production:
Methyl 3-amino-4-chloro-5-methoxybenzenecarboxylate is utilized in the production of dyes and pigments due to its chemical structure that can impart color to various materials. This makes it a valuable component in the manufacturing of colored products for different industries.
Used as a Building Block in Organic Chemistry:
Recognized for its potential as a building block in organic chemistry, Methyl 3-amino-4-chloro-5-methoxybenzenecarboxylate is employed in the creation of a wide range of chemical products. Its versatile reactivity allows for the synthesis of new compounds with diverse applications in various fields.

Upstream product

• 63603-09-8 methyl 4-chloro-3-methoxy-5-nitrobenzoate 
• 42590-00-1 4-hydroxy-3-methoxy-5-nitrobenzoic acid methyl ester 
• 3943-74-6 4-hydroxy-3-methoxybenzoic acid methyl ester 

Downstream Products

• 1141748-09-5 methyl 3-(bis(tert-butoxycarbonyl)amino)-4-chloro-5-methoxybenzoate 
• 63001-36-5 3,4-Dichloro-5-hydroxybenzoic acid 
• 945004-00-2 methyl 3,4-dichloro-5-methoxybenzoate 
• 1628540-03-3 methyl 3-bromo-4-chloro-5-methoxybenzoate 
• 93561-98-9 3-amino-4-chloro-5-hydroxybenzoic acid hydrobromide 

Relevant academic research and scientific papers

MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS

The present invention relates to macrocyclic diamine derivatives of formula II, including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the macrocyclic diamine derivatives with an adenosine receptor antagonist, for the treatment of cancers.

FUSED PYRIMIDINOPIPERIDINE DERIVATIVE, AND MANUFACTURING METHOD AND APPLICATION THEREOF

The present invention relates to the fused pyrimidine piperidine cyclic derivative represented by the following formula (I) and a pharmaceutically acceptable salt thereof and a process for preparing the same, wherein R1, R2, R3

Therapeutic Aryl-Amido-Aryl Compounds and Their Use

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-amido-aryl compounds of the following formula (for convenience, collectively referred to herein as “AAA compounds”), which, inter alia, a

THERAPEUTIC ARYL-AM I DO-ARYL COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-amido-aryl compounds of the following formula (for convenience, collectively referred to herein as "AAA compounds"), which, inter alia, a

Formal total synthesis of N-methylmaysenine

A novel synthetic approach for the formal total synthesis of N-methylmaysenine (1) has been developed. Key steps Involve the Ti-mediated vlnylogous Mukaiyama aldol reaction of chlral ketene silyl N,O-acetal with β-dithiane-substituted aldehyde, an aldol c